Cystic Fibrosis Therapeutics Market – Trends And Forecast, 2013 – 2019

Transparency Market Research Reports incorporated a definite business overview and investigation inclines on “Cystic Fibrosis Therapeutics Market“. This report likewise incorporates more illumination about fundamental review of the business including definitions, requisitions and worldwide business sector industry structure.

Cystic Fibrosis (CF), also known as mucoviscidosis, is a genetic disorders that affects the lungs, pancreas, liver and intestine. It is characterized by abnormal transport of chloride and sodium across the epithelium. It leads to secretion of stick and thick mucus, which obstruct pancreatic enzyme activity in the body.

Browse the full report with request TOC at http://www.transparencymarketresearch.com/cystic-fibrosis-therapeutics.html

Global market of CF therapeutics is rapidly growing, due to increased innovations and introduction of new drugs for the treatment of the disease. Rising prevalence of CF among large population base followed by increased R&D investment are also supporting factor for the growth of market. High price of CF modulators and complexity of pathophysiology are some of the factors that hinder the growth of this market. Development of new therapeutic techniques and development of safe anti-inflammatory therapies for the treatment of the disease are major opportunities for the market. Some of the major drug brands for the treatment of CF are Tobramycin, Podhaler, Colistimethate sodium, Colobrethe and Cayston.

The market of CF therapeutics is focused on epidemiology of disease in major countries of the world, such as the U.S., France, Germany and the U.K. The market is segmented on the basis of age, sex and mutation. Some of the major players operating in the market are Pari Pharma, AstraZeneca and Vertex Pharmaceuticals.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
North America
Asia Pacific
Europe
Rest of the World

This report provides comprehensive analysis of
Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Contact Us

Sheela AK
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Erythropoietin Market – 2013 – 2019

Erythropoietin is a type of a glycoprotein produced by body that controls red blood cell production in the body and is produced in kidneys. Kidney cells responsible for production of erythropoietin are sensitive to oxygen levels in the blood. Low levels of oxygen in the blood triggers the production and release of erythropoietin. Erythropoietin stimulates the bone marrow to produce red blood cells that ultimately carries oxygen and maintains the oxygen levels in the body. Thenormal range of erythropoietin is 4 to 24 mU/ml.

Browse the full report with request TOC at http://www.transparencymarketresearch.com/erythropoietin-market.html

Erythropoietin tests detects abnormal levels of erythropoietin in the blood thus indicating kidney diseases, bone marrow disorders and excess erythropoietin production.Erythropoietin is also used to correct anemic conditions by stimulating red blood cell production. Increasing incidences of anemia globally mainly resulting from chemotherapy and rapidly increasing morbidity rate of kidney disorders are driving the growth of the global erythropoietin market. While on the other hand, erythropoietin market has reached to saturation in developed countries thus restraining the growth of this market to some extent. Synthetic erythropoietin is produced using DNA recombinant technology. Erythropoietin market can be categorized on the basis of types of synthetic erythropoietin as follows:

Epoetin-alfa
Epoetin-beta
Epoetin-omega
Epoetin-delta
Darbepoetin-alfa

Further, based on application erythropoietin market is segmented as,
Oncology diseases
End stage renal disease (ESRD)
Pre-dialysis

Geographically the market is segmented into,
North America
Europe
Asia Pacific
Rest of the world

Currently, North America dominatesthe erythropoietin market and is followed by Europe due high spending capacity in the healthcare infrastructure in these regions. Asia-Pacific is a promising market for erythropoietin and is expected to undergo rapid market growth due to increase in purchasing power, rapidly improving healthcare infrastructure and increased medical tourism and the available treatments. Some of the major companies contributing to this market include Hospira Inc., Amgen Inc., Roche Diagnostics and Johnson & Johnson.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
North America
Asia Pacific
Europe
Rest of the World
This report provides comprehensive analysis of
Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Reasons for Buying this Report
This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth
It provides a technological growth map over time to understand the industry growth rate
It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
It provides distinctive graphics and exemplified SWOT analysis of major market segments

Nanotechnology Drug Delivery Market – Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 – 2019

Nanotechnology Drug Delivery MarketTransparency Market Research Reports included a detailed market survey and analysis trends on “Nanotechnology Drug Delivery Market”. This report also includes more info about basic overview of the industry including definitions, applications and global market industry structure.

Nanotechnology has opened a new path for drug delivery to specific cells with the usage of nanoparticles. Nanomedical approach for drug delivery is centered on the development of nanoscale molecules or particles to improve the drug efficiency. Drugs are loaded on nanoparticles or nanocarriers (size is between 1 and 100 nm) and then transported in to the targeted site. Nanoparticles are engineered in such a manner that they are attracted to the diseased cells and then allow direct treatment of those cells. Using nanotechnology drug delivery the overall drug consumption and side effects can be lowered significantly. The highly selective approach reduces the side effects and cost as well. The new methods of nano technology are being developed for the treatment of serious illness such as cancer.

Browse the full report with request TOC at http://www.transparencymarketresearch.com/nanotechnology-drug-delivery.html

The targeted drug delivery for the treatment of cancer is one of the most anticipated benefits of nanotechnology enabled medicine. The targeted therapy offer high accuracy that further surpasses the present available methods. The lack of specificity of currently available drug delivery method destroys healthy cells along with the diseased cells. Moreover, 90% of the drug is wasted in the body that leads to unwanted side effects. Hence, owing to the comparative benefits of nanotechnology drug delivery over traditional methods is witnessing a significant growth. Moreover, growth in the market is also driven due to low research and development cost. The global nanotechnology drug delivery market is segmented on the basis of different types of nanoparticles. Different type of nanoparticles segment comprises lipid-based nanocarriers, organic nanocarriers, inorganic nanocarriers and polymer based nanocarriers.

Currently, a paradigm shift is being observed in the healthcare industry towards personalized medicines that is further increasing the demand for nanomedicines. However, treatment through nanoparticles in not new, Abraxane was the first product that was launched for treatment of breast cancer. Presently, there are now hundreds of nanoparticulate drug delivery products available.

Some of the key players in this industry are Celgene Corporation, Alkermes PLC., Novartis AG, among others.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

  • North America
  • Asia Pacific
  • Europe
  • Rest of the World

This report provides comprehensive analysis of

  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Reasons for Buying this Report
This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth
It provides a technological growth map over time to understand the industry growth rate
It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
It provides distinctive graphics and exemplified SWOT analysis of major market segments

Browse all Market Research reports: http://www.transparencymarketresearch.com

Anti-Hypertensive Drugs Market – Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 – 2019

Pharmaceuticals copy

Hypertension is a chronic medical condition in which the arterial blood pressure is elevated to an undesired level. Also referred to as arterial hypertension or high blood pressure in generic terms, the condition is measured in terms of systolic and diastolic pressure. At rest blood pressure level is in the range of 120-140 mm Hg systolic and 60-90mm Hg diastolic. Hypertension arises when it is persistently at or above the 140/90mm Hg level. Primary hypertension, a condition with no underlying medical cause is highly prevalent than secondary hypertension which is caused by other conditions such as kidney, heart, endocrine or arterial disorders. Changing lifestyle habits such as diet, smoking and exercising are the major cause of hypertension. Hypertension is one of the most powerful risk factors for cardiovascular morbidity and mortality.

Browse Full Report with TOC: http://www.transparencymarketresearch.com/anti-hypertensive-drugs.html

Based on their therapeutic class, the anti-hypertensive drugs market is classified into diuretics, angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), calcium channel blockers, beta blockers, alpha blockers, vasodilators and renin inhibitors. These drugs find their therapeutic use as single drug administration or in fixed dose combinations. Diuretics are the first line of treatment recommended by the physicians for most patients. However, the drug preference depends on the patient’s medical history and current conditions. For instance, a hypertensive patient with diabetes may be recommended an ACE inhibitor as a first line treatment.

Hypertension is a lifelong disease, which means that a patient may require to take medications every day for the rest of his/her life. Thus, the demand for anti-hypertensive dugs is sustainable and will increase with increase in the number of target patients. Anti-hypertensive drugs were the second largest therapy area in 2011 with the global sales value of more than USD 40 billion, according to the World Preview 2018 report by Evaluate Pharma.

This market however, will be volatile due to patent expiries of blockbuster drugs, generic erosion, and launch of novel molecules. For example, the patent expiration of blockbuster drugs such as Diovan, Revatio, Avapro, Exforge and BIopress has impacted the global anti-hypertensive market with the entry of generics. On the other hand, the demand for fixed dose combinations is certain to rise, backed by the increase in number of patients. Factors such as aging population and lifestyle modifications will lead to an increase in the global incidence rate of hypertension.

Some of the key players contributing to the global anti-hypertensive drugs market include Novartis AG, Pfizer, Inc., Johnson & Johnson Ltd., Sanofi S.A., Lupin Limited, Ranbaxy Laboratories Limited, Merck & Co., Inc., Astra Zeneca Plc, Daiichi Sankyo Company Limited and Takeda Pharmaceutical Company Limited.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

  • North America
  • Asia Pacific
  • Europe
  • Rest of the World

This report provides comprehensive analysis of

  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Read More Reports on Pharmaceutical Markets: http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

About us

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information.Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

download-pdf (3)

Anti-Hypertensive Drugs Market – Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 – 2019

Contact Us

Sheela AK
Corporate Office:
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States.

Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

Browse Market Research Blog:
http://www.tmrblog.com/
http://businessindustryresearch.wordpress.com/
http://tmrmarkets.blogspot.com/

Ophthalmic Drugs Market

Ophthalmic Drugs Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2018

Transparency Market Research Reports included a detailed market survey and analysis trends on Ophthalmic Drugs Market. This report also includes more info about basic overview of the industry including definitions, applications and global market industry structure.

The global ophthalmic drugs market is rapidly growing due to increasing prevalence of eye disorders such as glaucoma, dry eye diseases and retinal diseases. Changing lifestyle, improved medical infrastructure, technological changes, increase in healthcare spending and aging population is also supporting the growth of the ophthalmic drugs market.

Browse Full Report:- http://www.transparencymarketresearch.com/ophthalmic-drugs-market.html

Glaucoma is the largest drugs segment in global ophthalmic drugs market. Some of the major drugs for glaucoma treatment are Lumigan, Combigan, Xalatan, Ganfort and Saflutan. Diquas, Hyalein and Restasis are the major drugs for dry eye diseases. The retinal drugs market includes Ozurdex, Macugen, Visudyne and Lucentis. Patanol/Pataday, Tobradex, Vigamox and Bepreve are major ocular anti-inflammatory drugs. The ophthalmic drugs market covers prescription based drugs, OTC drugs and pipeline drugs. This report forecasts future potential of all these drug markets and analyses drivers and opportunities, restraints and challenges, market trends, Porter’s forces, competitive landscape and company profiles of key players.

The report categorizes the global ophthalmic drugs market based on major eye disorders, treatment drugs and geography. The treatment drugs market comprises treatment of major eye disorders such as glaucoma, dry eye drugs, retinal diseases and ocular inflammatory diseases. The market is further segmented on the basis of prescription based drugs, OTC drugs and pipeline drugs in different eye disorder areas. In the segment of geographic analysis, the report identifies and analyses market sizes and forecast of North America, Europe, Asia Pacific and Rest of the World (RoW). North America region covers the scenario of the US. Europe region covers the scenario of France, Germany and the UK. Asia Pacific region highlights the scenario of India, China and Japan.

Table of Content
Chapter 1 Preface 8
Chapter 2 Executive Summary 10
Chapter 3 Ophthalmic Drugs – Industry Analysis 11
Chapter 4 Ophthalmic Drugs Market Trends 18
Chapter 5 Porter’s Five Force Analysis 20
Chapter 6 Global Market Size and Forecast 22
Chapter 7 Ophthalmic Drugs Market – Treatment Drugs 25
Chapter 8 Ophthalmic Drugs Market: Regional Analysis 34
Chapter 9 Prescription vs. Over the Counter Drugs 55
Chapter 10 Competitive Landscape 57
Chapter 11 Company Profiles 62

List of Figures

FIG. 1 Profiles of aging population in major countries (%, 2000-2050) 13
FIG. 2 Global ophthalmic drugs market: Porter’s five force analysis 20
FIG. 3 Key players market share in the global ophthalmic drugs market in 2012 57
FIG. 4 Ophthalmic drugs market strategic developments (2011-2013) 58

List of Tables

TABLE 1 Drivers for ophthalmic drugs market: Impact analysis 11
TABLE 2 Global data on visual impairment, by region (million, 2002 and 2010) 12
TABLE 3 Restraints for ophthalmic drugs market: Impact analysis 15
TABLE 4 Out of pocket expenditure of developing and developed countries 17
TABLE 5 Major combination therapy drugs worldwide 18
TABLE 6 Major merger and acquisitions in the ophthalmic drug market 19
TABLE 7 Global Ophthalmic drugs market size, by geography 2008-2012 (USD million) 22
TABLE 8 Global Ophthalmic drugs market size, by geography 2013-2018(USD millions) 23
TABLE 9 Global Ophthalmic drugs market size, by disease 2008-2012 (USD million) 23
TABLE 10 Global Ophthalmic drugs market size, by disease 2013-2018 (USD million) 24
TABLE 11 Dry eye drugs market 2010-2012 (USD million) 25
TABLE 12 Dry eye drugs market 2013-2018 (USD million) 26
TABLE 13 Major dry eye drugs pipeline 26
TABLE 14 Retinal drugs market 2010-2012 (USD million) 27
TABLE 15 Retinal drugs market 2013-2018 (USD million) 28
TABLE 16 Major retinal disease drugs pipeline 28
TABLE 17 Anti-allergy/inflammatory drugs market 2010-2012 (USD million) 29
TABLE 18 Anti-allergy/inflammatory drugs market 2013-2018 (USD million) 30
TABLE 19 Major anti-inflammatory/allergy/anti-infective drugs pipeline 30
TABLE 20 Prevalence of glaucoma, by geographic regions (million, 2010-2020) 31
TABLE 21 Major anti-glaucoma drugs market 2010-2012 (USD million) 32
TABLE 22 Major anti-glaucoma drugs market 2013-2018 (USD million) 32
TABLE 23 Anti-glaucoma drugs pipeline 33
TABLE 24 North America Ophthalmic drugs market size, by geography 2008-2012 (USD million) 34
TABLE 25 North America Ophthalmic drugs market size, by geography 2013-2018 (USD million) 35
TABLE 26 North America Ophthalmic drugs market size, by disease 2008-2012 (USD million) 35
TABLE 27 North America ophthalmic drugs market, by disease 2013-2018 (USD million) 36
TABLE 28 Ophthalmic drugs market, by disease in US 2008-2012(USD million) 37
TABLE 29 Ophthalmic drugs market by disease in US 2013-2018 (USD million) 37
TABLE 30 European Ophthalmic drugs market size, by geography 2008-2012 (USD million) 38
TABLE 31 European Ophthalmic drugs market size, by geography 2013-2018 (USD million) 39
TABLE 32 European ophthalmic drugs market by disease 2008-2012 (USD million) 40
TABLE 33 European ophthalmic drugs market by disease 2013-2018 (USD million) 40
TABLE 34 French ophthalmic drugs market by disease 2008-2012 (USD million) 41
TABLE 35 French ophthalmic drugs market, by disease 2013-2018 (USD million) 42
TABLE 36 German Ophthalmic drugs market, by disease 2008-2012 (USD million) 43
TABLE 37 German ophthalmic drugs market, by disease 2013-2018 (USD million) 43
TABLE 38 The UK ophthalmic drugs market, by disease 2008-2012 (USD million) 45
TABLE 39 The UK ophthalmic drugs market, by disease 2013-2018 (USD million) 45
TABLE 40 Asian Ophthalmic drugs market size, by country 2008-2012 (USD million) 46
TABLE 41 Asian Ophthalmic drugs market size, by geography 2013-2018 (USD million) 47
TABLE 42 Asian ophthalmic drugs market, by disease 2008-2012 (USD million) 47
TABLE 43 Asian ophthalmic drugs market, by disease 2013-2018 (USD million) 48
TABLE 44 Indian ophthalmic drugs market, by disease 2008-2012 (USD million) 49
TABLE 45 Indian ophthalmic drugs market, by disease 2013-2018 (USD million) 50
TABLE 46 Chinese ophthalmic drugs market, by disease 2008-2012 (USD million) 51
TABLE 47 Chinese ophthalmic drugs market, by disease 2013-2018 (USD million) 52
TABLE 48 Japanese ophthalmic drugs market, by disease 2008-2012 (USD million) 53
TABLE 49 Japanese ophthalmic drugs market, by disease 2013-2018 (USD million) 53
TABLE 50 Ophthalmic drugs market, by prescription vs. over the counter drugs 2008-2012 (USD million) 55
TABLE 51 Ophthalmic drugs market, by prescription vs. over the counter drugs 2013-2018 (USD million) 56
TABLE 52 Major product launches in ophthalmic drugs market (2011-2013) 59
TABLE 53 R&D initiatives in ophthalmic drugs market (2012-2013) 60
TABLE 54 Mergers and acquisitions in ophthalmic drugs market (2011-2013) 61

More Reports On Pharmaceutical Market: – http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

About Us:-
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us
Sheela AK
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Browse Market Research Report:-
http://www.tmrblog.com/
http://mrreports.wordpress.com/
http://marketsandresearch.blogspot.com/

Prenatal And New-Born Genetic Testing Market – Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 – 2019

Pharmaceuticals copy

Prenatal diagnosis or prenatal testing is performed for checking the diseases in a fetus or embryo before it is born. Although most of pregnancies end giving birth to a healthy baby but there remains chances where a child patient is born with defects.  Hence, the primary aim of the test refers to the detection of birth defects such as Down syndrome, chromosomal abnormalities, neural tube defects and genetic diseases.  In addition, diseases such as sickle cell anemia, thalassemia, cystic fibrosis are others are also identified using prenatal diagnosis. Sometimes tests are done to determine high risk pregnancies early so that a delivery can be scheduled accordingly. Presently, prenatal testing is also performed for determining the characteristics generally not related to birth defects.  Prenatal diagnosis is performed primarily for two reasons that include timely execution of medical or surgical treatment and to give parents the chance for abortion at an early stage. For, instance an ultrasound performed at 18 to 20 days of pregnancy can detect many physical changes.

Browse Full Report with TOChttp://www.transparencymarketresearch.com/prenatal-new-born-genetic-testing.html

Blood tests are done for performing new born screening. Through new born screening many disorders can be treated at an early stage.  Level of phenylketonuria is (PKU) is checked through blood test. PKU is a genetic disorder that is caused by the mutation in the gene for hepatic enzyme that is necessary to metabolize the amino acids. Hence if PKU is left untreated then it might cause mental impairment. Moreover, thyroid level is also checked, because hypothyroidism leads to disability in the growth. Down’s syndrome is a commonly occurring genetic disease that can be identified through prenatal testing. Amniocentesis or chorionic villus sampling is performed to examine the number of chromosomes.

Prenatal testing and newborn screening market is witnessing a considerable rise owing to rise in genetic disorders. Early diagnosis can avoid the complications with the help of prompt treatment. However, there are disparities related to the tests that are restraining the growth of this market. Major players capturing the market space include Genzyme Genetics, Biogen, Ferring Pharmaceuticals, Novartis AG and others.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

  • North America
  • Asia Pacific
  • Europe
  • Rest of the World

This report provides comprehensive analysis of 

  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

More Reports On Pharmaceutical Markethttp://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

About us

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information.Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Download PDF FilePrenatal And New-Born Genetic Testing Market – Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 – 2019

Contact Us

Sheela AK
Corporate Office:
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States.

Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

Browse Market Research Blog: 
http://pharmaceuticalbusinessresaerch.wordpress.com/
http://market2researchreport.blogspot.com/

Pneumonia Drugs & Vaccines Market – Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 – 2019

525928_357561407618243_2064896067_n

Pneumonia is a common lung infection caused by a variety of microorganisms such as bacteria, virus, fungi and parasites. In pneumonia the air sacs of lungs that are known as alveoli are filled with fluid or pus causing inflammation. The common symptoms of pneumonia are cough with phlegm, sneezing, sore throat, chills, fever and trouble in breathing. Pneumonia is usually a mild disease but under certain situations can be lethal. Children, elderly people and those with recent viral infections, lung disease and heart disease are at higher risk of developing pneumonia compared to general population. Pneumonia is of different types depending on the way it has been acquired by people such community acquired pneumonia (CAP), hospital acquired pneumonia (HAP) and healthcare associated pneumonia as patient may also develop pneumonia during their visits to other healthcare setting such as nursing homes, dialysis centers and outpatient clinics. Others are aspiration pneumonia and atypical pneumonia. Pneumonia is one of the most common hospital acquired infection.

Browse Full Report with TOChttp://www.transparencymarketresearch.com/pneumonia-drugs-vaccines-market.html

The global market for pneumonia is segmented broadly into treatment drugs and prevention vaccines market. Usually antibiotics used to treat pneumonia include cephalosporins, penicillin, tetracyclines, fluoroquinolones, amoxicillin, clavulanic acid and vancomycin. Earlier, penicillin was widely used to treat pneumonia caused by bacteria pnemococcal pneumonia but due to wide spread use of broad spectrum antibiotics has resulted into significant drug resistance. Penicillin is still used but only after confirming the sensitivity of the bacteria towards this antibiotic. Pneumococcal conjugate vaccine such as PCV13 and pneumococcal polysaccharide vaccines such as PPV23 and Pneumovax are used to prevent pneumococcal diseases. The major players operating in this market are Sanofi, Eli Lilly, AstraZeneca, Merck & Co. Novartis, GlaxoSmithCline, Pfizer and Baxter International Inc.

The market for pneumonia drugs and vaccines is expected to grow under the impact of drivers such as increasing aging population as aging population are more susceptible to developing pneumonia and increasing prevalence of pneumonia among children. According to WHO, every year approximately 1.2 million children under the age of five years die because of pneumonia. WHO also reports only 30% of children suffering from pneumonia get required antibiotics for the treatment of pneumonia. This disease is most prevalent in South Asia and African countries.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. 

Geographies analyzed under this research report include 

  • North America
  • Asia Pacific
  • Europe
  • Rest of the World

This report provides comprehensive analysis of 

  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

More Reports On Pharmaceutical Markethttp://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

About us

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

Pharmaceuticals copy

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information.Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Download PDF FilePneumonia Drugs & Vaccines Market – Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 – 2019

Contact Us

Sheela AK
Corporate Office:
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States.

Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

Browse Market Research Blog:
http://tmrmarkets.blogspot.com/